The significant tumor mass increase occurred in response to protumor cellular events, such as fewer CD3+ cells and signaling changes, such as higher IL‐1β levels and lower levels of IL‐12p70, IL‐23 and IFN‐β, in the TME. This evidence concerns the gene IFNB1 and neoplasm.